Schedule 13G ownership disclosure
G1 THERAPEUTICS INC
Security class unavailable · CUSIP: 3621LQ109
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,237,342
- Percent of class
- 3.2500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-21-000063
- Form type
- SC 13G
- Filer
- G1 Therapeutics, Inc.
- CIK
- CIK 1560241
- Filed
- Feb 03, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership